Your browser doesn't support javascript.
loading
Hepatitis C Virus and Molecular Mimicry.
Goh, Lynette; Kerkar, Nanda.
Afiliación
  • Goh L; KK Women's and Children's Hospital, Singapore 229899, Singapore.
  • Kerkar N; Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02114, USA.
Pathogens ; 13(7)2024 Jun 22.
Article en En | MEDLINE | ID: mdl-39057754
ABSTRACT
This review delves into the interactions between hepatitis C virus (HCV) and the host immune system, shedding light on how by using the mechanism of molecular mimicry, the virus strategically evades the immune system, resulting in a cascade of diverse complications. HCV, notorious for its ability to persistently infect hepatocytes, employs molecular mimicry to resemble host proteins, thereby avoiding immune detection and mounting an effective defense. This mimicry also triggers systemic autoimmune responses that lead to various sequelae. The objective of this review is to comprehensively explore the role of HCV-induced molecular mimicry, which not only facilitates viral survival but is also instrumental in developing autoimmune and inflammatory disorders. By mimicking host proteins, HCV triggers an immune response that inadvertently attacks the host, fostering the development of autoimmune and other inflammatory disorders. Understanding the nuanced mechanisms of HCV-mediated molecular mimicry provides crucial insights into the multifaceted sequelae of viral infections on host immune responses. Unravelling these complexities is paramount for advancing therapeutic strategies that not only target the virus directly but also mitigate the secondary autoimmune and inflammatory complications induced by HCV.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pathogens Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pathogens Año: 2024 Tipo del documento: Article